financetom
Market
financetom
/
Market
/
ICICI Prudential shares up 6% after June quarter results; should investors buy, sell or hold?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ICICI Prudential shares up 6% after June quarter results; should investors buy, sell or hold?
Jul 22, 2021 1:29 AM

Shares of ICICI Prudential Life Insurance were up almost six percent on Thursday on the BSE after the insurer on Tuesday opened the earnings seasons for the life insurance sector with a massive Rs 500 crore claims arising due to the coronavirus pandemic and reported a net loss of Rs 185.73 crore for the quarter ended June.

Share Market Live

NSE

However, the company reported good all-around numbers, including a 71 percent growth in the key metric of the value of the new business premium. The second-largest private-sector life insurer had posted a net profit of Rs 287.59 crore in the year-ago period. In the previous quarter (January-March 2021), the insurer reported a profit of Rs 63.78 crore..

In a regulatory filing, ICICI Prudential said that the total income was down at Rs 16,724.05 crore in the quarter under review as against Rs 19,057.42 crore in the year-ago period. Of this, the net premium income was Rs 6,601.85 crore as against Rs 5,551.07 crore.

Here’s what brokerages have to say on ICICI Prudential’s stock and Q1 performance:

CLSA

The brokerage has maintained a 'buy' rating on the stock after its June quarter earnings with a target at Rs 725 per share. It noted that the company's first-quarter performance beat estimates notably with its VNB margin at 29.4 percent. The brokerage expects a VNB CAGR of 25% over FY21-23 and lifts the VNB estimates by 13-14 percent.

City

The brokerage has a 'buy' rating on the stock with the target at Rs 750 per share. It noted that the company's favourable product mix is driving VNB margin expansion. The brokerage has raised the company’s FY22/FY23 VNB estimates by six percent /three percent as they factor in the higher VNB margin. It has also lowered its FY22/FY23 profit estimates by 18 percent/13 percent as they factor in higher claims owing to COVID-19 pandemic and Opex.

Morgan Stanley

The brokerage has a 'buy' call on the stock with the target at Rs 700 per share. It noted that the company delivered a 20 percent VNB beat in a tough quarter. This pickup in VNB growth after recent sluggish growth should help rerate the stock, the brokerage said.

Goldman Sachs

The brokerage has a 'neutral' rating on the stock with the target at Rs 570 per share. The brokerage said, “ICICI Prudential’s Q1 beat was driven by group term, tops up COVID provisions. We revise FY22E-FY24 VNB estimates higher by up to two percent.”

The brokerage also said that the FY23 VNB guidance implies a CAGR of 28 percent over the next two years which is seemingly a tough act to achieve.

UBS

The brokerage has a 'buy' call on the stock with the target at Rs 690 per share. It noted that the company's strong core business performance will overshadow its weak accounting profits. The brokerage also noted that elevated claims and higher COVID reserving dents profitability.

It expects VNB margin to normalise with an evolving product mix. The company maintained its guidance to double its FY19 VNB by FY23, in line with estimates.

First Published:Jul 22, 2021 10:29 AM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Opening Bell: Sensex jumps 300 points, Nifty opens above 10,700 as financials lead
Opening Bell: Sensex jumps 300 points, Nifty opens above 10,700 as financials lead
Jul 6, 2020
The Indian equity benchmark indices opened higher on Monday led by buying across the sectors amid positive trends in Asian peers.
CLSA picks Sun Pharma over Lupin despite the latter performing better. Here's why
CLSA picks Sun Pharma over Lupin despite the latter performing better. Here's why
Jul 6, 2020
The pharma companies had a great run in the first half of this year and are most likely to continue...
Here are top 10 stock picks by Angel Broking for July 2020
Here are top 10 stock picks by Angel Broking for July 2020
Jul 6, 2020
Markets have staged a smart recovery since April with the Nifty rallying by almost 40 percent from its lows of 7,511 on March 24, 2020. The market was supported by a global risk on rally as central banks and government have responded with unprecedented monetary and fiscal stimuli in order to contain the economic damage due to the COVID-19 crisis. Stimulus package along with opening up of the Indian economy from June has led to increase in economic activities which has helped market sentiments. While Angel Broking remains positive on the markets from a longer term perspective, they feel that investors should be judicious in their stock selection and focus on companies with high quality business franchises which have strong revenue visibility going forward. Here's a list of top 10 stocks to buy in month of July, according to Jyoti Roy, DVP Equity Strategist, Angel Broking:
MarketBuzz Podcast With Sonia Shenoy: Sensex, Nifty likely to open higher; HDFC Bank, IndusInd Bank, ICICI Bank in focus
MarketBuzz Podcast With Sonia Shenoy: Sensex, Nifty likely to open higher; HDFC Bank, IndusInd Bank, ICICI Bank in focus
Jul 5, 2020
The Indian market is expected to open higher on Monday given strong momentum in global peers.
Copyright 2023-2025 - www.financetom.com All Rights Reserved